KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 23,014 Value ($000) $55 Avg Close — Range —
Q3 2023
Shares 32,309 Value ($000) $45 Avg Close — Range —
Q2 2023
Shares 28,754 Value ($000) $87 Avg Close — Range —